MS Speaks

Multiple Sclerosis => TREATMENTS => LEMTRADA (Campath, alemtuzumab) => Topic started by: agate on April 20, 2020, 08:29:55 am

Title: (Abst.) Acute cardiotoxicity associated w/alemtuzumab infusion for MS
Post by: agate on April 20, 2020, 08:29:55 am

From Multiple Sclerosis Journal (April 20, 2020)--"Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclerosis":


https://journals.sagepub.com/doi/abs/10.1177/1352458519855725


The first part of an editorial commentary on this case, in the same issue of the MS Journal--"Alemtuzumab: Rare serious adverse events of a high-efficacy drug":


https://journals.sagepub.com/doi/abs/10.1177/1352458520913277